Immunopathological mechanisms and targeted intervention strategies for chronic chikungunya arthritis: from viral persistence to autoimmunity
Open Access
- 27 April 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1775493
Abstract
Chronic chikungunya arthritis (CCA) is a major long-term sequela of Chikungunya virus (CHIKV) infection. Its pathogenesis involves persistent viral reservoirs in joint tissues, metabolic reprogramming of myeloid cells, dysregulated Treg/Th17 immunity, and autoimmune-like tissue injury. This review integrates recent advances in virology, immunometabolism, and clinical pathology to propose a four-stage pathological cascade: “viral persistence”, “myeloid metabolic dysregulation”, “Treg/Th17 imbalance”, and “autoimmunity-like injury”. Key cytokine networks and molecular interactions at each stage are summarized. Based on this model, we outline stage-specific therapeutic strategies, including antiviral agents targeting Mxra8 or nsP1 (Stage I), metabolic modulators such as HIF-1α inhibitors and IL-1β blockade (Stage II), immune-restorative therapies such as low-dose IL-2 and CTLA-4-Ig (Stage III), and anti-inflammatory biologics or DMARDs for RA-like pathology (Stage IV). This framework provides a mechanistic basis for precision intervention and supports the development of biomarkers and clinical trial designs for CCA.Keywords
This publication has 131 references indexed in Scilit:
- Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virusMedcomm, 2025
- Transcriptional and posttranslational regulation of Th17/Treg balance in health and diseaseEuropean Journal of Immunology, 2021
- Inhibition of Chikungunya virus by an adenosine analog targeting the SAM‐dependent nsP1 methyltransferaseFEBS Letters, 2019
- Treatment of Chronic Chikungunya Arthritis With Methotrexate: A Systematic ReviewArthritis Care & Research, 2018
- Review: Chikungunya Arthritis: Implications of Acute and Chronic Inflammation Mechanisms on Disease ManagementArthritis & Rheumatology, 2017
- The role of autoantibodies in the pathophysiology of rheumatoid arthritisSeminars in Immunopathology, 2017
- Brief Report: Management of Chronic Post‐Chikungunya Rheumatic Disease: The Martinican ExperienceArthritis & Rheumatology, 2016
- Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label studyClinical Rheumatology, 2016
- Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief reportClinical Rheumatology, 2016
- Prevalence of Post‐Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta‐AnalysisArthritis Care & Research, 2016